...looks like this would be one of your competitors.
Not really. It looks to me like this product is a treatment for nociceptive pain, not neuropathic pain like ACV1.
Two different indications, two different markets.
- Forums
- ASX - By Stock
- MBP
- volume building for mbp
volume building for mbp, page-16
Featured News
Add MBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online